Article

eAbstract: Autoantibodies against Bactericidal/Permeability-increasing Protein (BPI) in Children with Acute Pneumonia

Study authors aimed to determine whether serum and salivary anti-BPI autoantibodies also appear in the course of acute pneumonia in 24 otherwise healthy children.

Results from this study show that serum and salivary anti-BPI autoantibodies do not increase during the course of acute pneumonia.

Autoantibodies against Bactericidal/Permeability-increasing Protein (BPI) in Children with Acute Pneumonia

Journal: FEMS Immunology and Medical Microbiology (November 2009)

Authors: Steiner P, Otth M, Casaulta C, et al.

Purpose: To determine “whether serum and salivary anti-BPI autoantibodies also appear in the course of acute pneumonia in 24 otherwise healthy children.”

Results: “Nine (38%) and four (17%) patients had detectable serum anti-BPI immunoglobulin G (IgG) (> or =4 IU mL(-1)) and IgA (ratio> or =1.2), respectively, on the day of hospital admission (day 0). There was no increase in the rate of occurrence or the concentration of these antibodies in the convalescent sera obtained on day 30.”

Related Videos
Using Microbiomes to Diagnose Ventilator-Associated Pneumonia
Tailoring Chest Pain Diagnostics to Patients, with Kyle Fortman, PA-C, MBA
Solutions to Prevent Climate Change-Related Illness, with Janelle Bludhorn, PA-C
Kyle Fortman, PA-C, MBA: Troponin and Heart Injury Risk Screening Recommendations
What Should the American Academy of Physician Associates Focus on in 2025?
The Rising Rate of Heat-Related Illness, with Janelle Bludhorn, PA-C
Mikkael Sekeres, MD:
© 2024 MJH Life Sciences

All rights reserved.